Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.
(Studio) No. Americans suffering from arthritis mentioned.
REPORTER: Dan Rather
(NYC) Controversy surrounding arthritis treatment involving drug Oraflex examined; Ben Fishbein's case cited as example [FISHBEIN - notes improved life with Oraflex.] British medical reports of deaths believed associated with use of Oraflex outlined on screen. ["Public Citizen" spokesperson Dr. Eve BARGMANN - doesn't consider death an acceptable side effect.] Eli Lilly and Company's response to criticism noted. [Company spokesperson Dr. Ian SHEDDEN - expresses concern.] [National Insts. of Health spokesperson Dr. John DECKER - considers drug too much trouble to use.] Dilemma faced by arthritis victims outlined.
REPORTER: David Culhane
- Culhane, David;
- Rather, Dan
Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.
Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:
- You may request a loan of this video by registering on our website and placing an order.
- You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
- If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.
If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.